同工酶选择性环核苷酸磷酸二酯酶抑制剂：哮喘中的生物化学、药理学及治疗潜力 - Suppr

Suppr

超能文献

Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: biochemistry, pharmacology and therapeutic potential in asthma.

作者信息

Raeburn D, Souness J E, Tomkinson A, Karlsson J A

机构信息

Rhône-Poulenc Rorer Ltd., Dagenham Research Centre, Dagenham, Essex, England.

出版信息

Prog Drug Res. 1993;40:9-32. doi: 10.1007/978-3-0348-7147-1_3.

DOI:10.1007/978-3-0348-7147-1_3

PMID:8395068

Abstract

摘要

相似文献

Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: biochemistry, pharmacology and therapeutic potential in asthma.

Prog Drug Res. 1993;40:9-32. doi: 10.1007/978-3-0348-7147-1_3.

Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.

Trends Pharmacol Sci. 1991 Jan;12(1):19-27. doi: 10.1016/0165-6147(91)90484-a.

Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.

Biochem Soc Trans. 1992 May;20(2):460-4. doi: 10.1042/bst0200460.

Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma.

Clin Exp Allergy. 1992 Mar;22(3):337-44. doi: 10.1111/j.1365-2222.1992.tb03095.x.

Cyclic nucleotide phosphodiesterase isoenzymes and asthma--outstanding issues.

Agents Actions Suppl. 1993;43:3-12. doi: 10.1007/978-3-0348-7324-6_1.

Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function.

Pharmacol Ther. 1991;51(1):13-33. doi: 10.1016/0163-7258(91)90039-o.

Role of cyclic nucleotide phosphodiesterase isoenzymes in contractile responses of denuded rat aorta related to various Ca2+ sources.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Jun;363(6):612-9. doi: 10.1007/s002100100397.

Therapeutic potential of isozyme-selective phosphodiesterase inhibitors in the treatment of asthma.

Adv Second Messenger Phosphoprotein Res. 1992;25:289-305.

[Progress in the study of cyclic nucleotide phosphodiesterases].

Sheng Li Ke Xue Jin Zhan. 1995 Jul;26(3):213-7.

Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.

J Pharmacol Exp Ther. 1995 Aug;274(2):678-87.

引用本文的文献

Phosphodiesterase V inhibition reduces airway responsiveness, but does not improve the beneficial effect of deep inspiration.

Respiration. 2013;86(3):243-51. doi: 10.1159/000350451. Epub 2013 Jul 16.

Changes in A-type natriuretic peptide and its receptors induced by a neutral endopeptidase inhibitor in a rat model of sepsis.

Surg Today. 2008;38(2):130-4. doi: 10.1007/s00595-007-3586-5. Epub 2008 Feb 1.

Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?

Drugs. 2000 Feb;59(2):193-212. doi: 10.2165/00003495-200059020-00004.

Effect of selective phosphodiesterase 3 inhibition on the early and late asthmatic responses to inhaled allergen.

Br J Clin Pharmacol. 1998 Apr;45(4):387-91. doi: 10.1046/j.1365-2125.1998.t01-1-00689.x.

Intracellular localization of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in stably transfected human thyroid carcinoma FTC cell lines.

Biochem J. 1997 Jan 1;321 ( Pt 1)(Pt 1):177-85. doi: 10.1042/bj3210177.

The effect of isoenzyme-selective PDE inhibitors on methacholine-induced contraction of guinea-pig and rat ileum.

Br J Pharmacol. 1996 Aug;118(8):2131-9. doi: 10.1111/j.1476-5381.1996.tb15653.x.

Cytokine production by phytohemagglutinin-stimulated human blood cells: effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors.

Inflamm Res. 1995 Sep;44(9):400-5. doi: 10.1007/BF01797868.

Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.

Br J Pharmacol. 1994 Apr;111(4):1081-8. doi: 10.1111/j.1476-5381.1994.tb14855.x.

Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor.

Br J Pharmacol. 1994 Dec;113(4):1423-31. doi: 10.1111/j.1476-5381.1994.tb17156.x.

Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram.

Br J Pharmacol. 1995 May;115(1):39-46. doi: 10.1111/j.1476-5381.1995.tb16317.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验